1-8 of 8
Philip Lewis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health-Related Quality of Life in Lenalidomide and Bortezomib Treated Patients with Relapsed/Refractory Multiple Myeloma

Charalampia Kyriakou, MD PhD, Philip Murphy, MD, Maria Teresa Petrucci, MD, Pamela Bacon, Philip Lewis, Hélène Gilet, MSc, Benoit Arnould, PhD, Isabelle Vande Broek, MD PhD, Xavier Leleu, MD
Journal: Blood
Blood (2015) 126 (23): 2085.
https://doi.org/10.1182/blood.V126.23.2085.2085
Published: 2015
Journal Articles

Assessment of Multiple Myeloma Patient Preferences on Treatment Choices: An International Discrete Choice Study

Xavier Leleu, Maria-Victoria Mateos, Michel Delforge, Philip Lewis, Thomas Schindler, Craig Gibson, Min Yang, Katja C. Weisel
Journal: Blood
Blood (2015) 126 (23): 2086.
https://doi.org/10.1182/blood.V126.23.2086.2086
Published: 2015
Journal Articles

Psychometric Performance Of The EORTC Quality-Of-Life Core Questionnaire (QLQ-C30) and QLQ-Multiple Myeloma (QLQ-MY20) In Relapsed/Refractory Multiple Myeloma (RRMM)

Xavier Leleu, MD, PhD, Maria Teresa Petrucci, MD, Manfred Welslau, Isabelle Vande Broek, Philip T Murphy, MD, MRCPath, Andrew Bottomley, PhD, Pamela Bacon, Philip Lewis, PhD, Hélène Gilet, MSc, Benoit Arnould, PhD, Charalampia Kyriakou
Journal: Blood
Blood (2013) 122 (21): 1721.
https://doi.org/10.1182/blood.V122.21.1721.1721
Published: 2013
Journal Articles

Continued Treatment Duration, Drug dosing  and Health-Related Quality Of Life (HRQoL) Of Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving 2 nd and 3 rd Line Treatments: Results From a European Multicentre Study

Maria Teresa Petrucci, MD, Xavier Leleu, MD, PhD, Charalampia Kyriakou, Isabelle Vande Broek, PhD, Philip T Murphy, MD, MRCPath, Philip Lewis, PhD, Pamela Bacon, Benoit Arnould, PhD, Manfred Welslau
Journal: Blood
Blood (2013) 122 (21): 5368.
https://doi.org/10.1182/blood.V122.21.5368.5368
Published: 2013
Journal Articles

Melphalan, Prednisone and Lenalidomide Followed by Lenalidomide Maintenance Displays Treatment Characteristics Favourable to Global Quality of Life in Newly Diagnosed Multiple Myeloma (NDMM) Patients ≥ 65 Years,

Meletios Athanasios Dimopoulos, MD, Antonio Palumbo, MD, Roman Hajek, MD, PhD, Martin Kropff, MD, Maria Teresa Petrucci, MD, Philip Lewis, PhD, Stefanie Millar, Jingshan Zhang, PhD, Jay Mei, MD, PhD, Michel Delforge, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3988.
https://doi.org/10.1182/blood.V118.21.3988.3988
Published: 2011
Journal Articles

Melphalan, Prednisone and Lenalidomide Followed by Lenalidomide Maintenance Improves Health-Related Quality of Life (HRQoL), with Newly Diagnosed Multiple Myeloma (NDMM) Patients ≥ 65 Years Benefiting From Delays in Disease Progression

Meletios Athanasios Dimopoulos, MD, Michel Delforge, MD, PhD, Roman Hajek, MD, PhD, Martin Kropff, MD, Maria Teresa Petrucci, MD, Philip Lewis, PhD, Stefanie Millar, Jingshan Zhang, PhD, Jay Mei, MD, PhD, Antonio Palumbo, MD
Journal: Blood
Blood (2011) 118 (21): 3157.
https://doi.org/10.1182/blood.V118.21.3157.3157
Published: 2011
Journal Articles

Determinants of Global QOL and Physical and Social Functionality In Multiple Myeloma

Karin Jordan, PhD, K. Jack Ishak, PhD, Philip Lewis, PhD, Irina Proskorovsky, MSc, Krista A Payne, M.Ed, Noreen Lordan, BSc, Charalampia Kyriakou, MD, PhD, Faith Davies, Sarah Peters, Catherine D Williams, MD
Journal: Blood
Blood (2010) 116 (21): 934.
https://doi.org/10.1182/blood.V116.21.934.934
Published: 2010
Journal Articles

Components of Global Quality of Life In Multiple Myeloma

Catherine D Williams, MD, Irina Proskorovsky, MSc, Philip Lewis, PhD, K. Jack Ishak, PhD, Krista A Payne, M.Ed, Noreen Lordan, BSc, Charalampia Kyriakou, MD, PhD, Faith Davies, MD, Sarah Peters, Karin Jordan, PhD
Journal: Blood
Blood (2010) 116 (21): 4735.
https://doi.org/10.1182/blood.V116.21.4735.4735
Published: 2010